BioCentury | Apr 6, 2021
Distillery Therapeutics

Herb-extracted compound triptonide identified as male contraceptive

...Research Institute of Guangdong Province, Guangzhou, Chinaemail: tyg813@126.comCONTACT: Wei Yan, University of Nevada, Reno School of Medicine, Reno, Nev.; Lundquist Institute...
BioCentury | Feb 1, 2020
Company News

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

...unit for the Pfizer Vaccines unit of Pfizer Inc. (NYSE:PFE). The Lundquist Institute , formerly the Los Angeles Biomedical Research Institute...
...and Gene Therapy Catapult RedShift BioAnalytics Inc. Vaxcyte Inc. NeoImmuneTech Inc. Insmed Inc. Moderna Inc. Bavarian Nordic A/S Anika Therapeutics Inc. Aprecia Pharmaceuticals Co. Lundquist Institute Lundquist Institute...
BioCentury | Aug 9, 2019
Preclinical News

Aug. 8 Preclinical Quick Takes: Mayo Clinic assay for residual disease; plus camouflage for bacterial agents, Elicio's KRAS vaccine and more

...for triple-negative breast cancer (TNBC). LA BioMed, NovaDigm vaccine for drug-resistant emerging fungal infection The Los Angeles Biomedical Research Institute...
...subunit α polypeptide Hongjiang Li and Sandi Wong, Staff Writers leronlimab (PRO 140) NDV-3A, NDV-3 Cleveland Clinic CytoDyn Inc. Elicio Therapeutics Inc. Lundquist Institute Mayo...
BioCentury | Jul 25, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: June 2019

...combination with approved antifungals, could help treat the invasive and often fatal fungal infection mucormycosis. Los Angeles Biomedical Research Institute...
BioCentury | Jun 14, 2019
Preclinical News

June 13 Preclinical Quick Takes: A*STAR's mAb against tumor-displayed antigen; plus Columbia, Genentech and more

...likely to engage in spontaneous synaptic activity. LA BioMed spinout Vitalex developing antifungal mAb The Los Angeles Biomedical Research Institute...
...phosphatase type IVA 3 Sandi Wong, Staff Writer Agency for Science Technology and Research Columbia University Crown Bioscience Inc. Genentech Inc. Lundquist Institute University...
BioCentury | Dec 13, 2016
Distillery Therapeutics

Infectious disease

...2016 doi:10.1038/nmicrobiol.2016.211 CONTACT: Scott Filler, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, Calif. email: sfiller@ucla.edu Michael J. Haas Lundquist Institute A...
BioCentury | Oct 16, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...eneufeld@mednet.ucla.edu Contact: Mika Aoyagi-Scharber, BioMarin Pharmaceutical Inc., Novato, Calif. e-mail: maoyagi-scharber@bmrn.com Contact: Patricia I. Dickson, Los Angeles Biomedical Research Institute...
BioCentury | Jun 30, 2014
Company News

NovaDigm, Harbor-UCLA Medical Center deal

...cell wall protein 1 ( Hyr1 ), a Candida vaccine antigen, from Harbor-UCLA Medical Center’s Los Angeles BioMedical Research Institute...
BioCentury | Sep 6, 2012
Cover Story

New home for bromodomains

...BRDT. Christina Wang, professor of medicine in the Division of Endocrinology & Metabolism at the Los Angeles Biomedical Research Institute...
...Washington, D.C. Harbor-UCLA Medical Center , Torrance, Calif. Harvard Medical School , Boston, Mass. Los Angeles Biomedical Research Institute...
BioCentury | Mar 19, 2012
Regulation

Feasible, perhaps not relevant

...we were not able to do so," said Brad Spellberg, professor of medicine at the Los Angeles Biomedical Research Institute...
Items per page:
1 - 10 of 12
BioCentury | Apr 6, 2021
Distillery Therapeutics

Herb-extracted compound triptonide identified as male contraceptive

...Research Institute of Guangdong Province, Guangzhou, Chinaemail: tyg813@126.comCONTACT: Wei Yan, University of Nevada, Reno School of Medicine, Reno, Nev.; Lundquist Institute...
BioCentury | Feb 1, 2020
Company News

Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

...unit for the Pfizer Vaccines unit of Pfizer Inc. (NYSE:PFE). The Lundquist Institute , formerly the Los Angeles Biomedical Research Institute...
...and Gene Therapy Catapult RedShift BioAnalytics Inc. Vaxcyte Inc. NeoImmuneTech Inc. Insmed Inc. Moderna Inc. Bavarian Nordic A/S Anika Therapeutics Inc. Aprecia Pharmaceuticals Co. Lundquist Institute Lundquist Institute...
BioCentury | Aug 9, 2019
Preclinical News

Aug. 8 Preclinical Quick Takes: Mayo Clinic assay for residual disease; plus camouflage for bacterial agents, Elicio's KRAS vaccine and more

...for triple-negative breast cancer (TNBC). LA BioMed, NovaDigm vaccine for drug-resistant emerging fungal infection The Los Angeles Biomedical Research Institute...
...subunit α polypeptide Hongjiang Li and Sandi Wong, Staff Writers leronlimab (PRO 140) NDV-3A, NDV-3 Cleveland Clinic CytoDyn Inc. Elicio Therapeutics Inc. Lundquist Institute Mayo...
BioCentury | Jul 25, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: June 2019

...combination with approved antifungals, could help treat the invasive and often fatal fungal infection mucormycosis. Los Angeles Biomedical Research Institute...
BioCentury | Jun 14, 2019
Preclinical News

June 13 Preclinical Quick Takes: A*STAR's mAb against tumor-displayed antigen; plus Columbia, Genentech and more

...likely to engage in spontaneous synaptic activity. LA BioMed spinout Vitalex developing antifungal mAb The Los Angeles Biomedical Research Institute...
...phosphatase type IVA 3 Sandi Wong, Staff Writer Agency for Science Technology and Research Columbia University Crown Bioscience Inc. Genentech Inc. Lundquist Institute University...
BioCentury | Dec 13, 2016
Distillery Therapeutics

Infectious disease

...2016 doi:10.1038/nmicrobiol.2016.211 CONTACT: Scott Filler, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, Calif. email: sfiller@ucla.edu Michael J. Haas Lundquist Institute A...
BioCentury | Oct 16, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...eneufeld@mednet.ucla.edu Contact: Mika Aoyagi-Scharber, BioMarin Pharmaceutical Inc., Novato, Calif. e-mail: maoyagi-scharber@bmrn.com Contact: Patricia I. Dickson, Los Angeles Biomedical Research Institute...
BioCentury | Jun 30, 2014
Company News

NovaDigm, Harbor-UCLA Medical Center deal

...cell wall protein 1 ( Hyr1 ), a Candida vaccine antigen, from Harbor-UCLA Medical Center’s Los Angeles BioMedical Research Institute...
BioCentury | Sep 6, 2012
Cover Story

New home for bromodomains

...BRDT. Christina Wang, professor of medicine in the Division of Endocrinology & Metabolism at the Los Angeles Biomedical Research Institute...
...Washington, D.C. Harbor-UCLA Medical Center , Torrance, Calif. Harvard Medical School , Boston, Mass. Los Angeles Biomedical Research Institute...
BioCentury | Mar 19, 2012
Regulation

Feasible, perhaps not relevant

...we were not able to do so," said Brad Spellberg, professor of medicine at the Los Angeles Biomedical Research Institute...
Items per page:
1 - 10 of 12